Pharming Group N.V Cash Flow Statement (2019-2025) | PHAR

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2019 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -29.72M-9.53M0.02M25.68M-25.67M5.70M5.00M23.37M7.94M28.38M-18.20M-9.96M1.75M-6.05M-20.51M-19.75M6.66M-3.41M9.43M90.22M
Share-based Compensation 0.83M4.17M-3.70M1.91M1.07M1.07M3.97M
Gains from Equity Investments 8.23M7.93M
Gains from Investment Securities -2.78M-0.00M0.15M160.70M161.37M147.87M141.85M136.92M0.13M148.30M144.73M146.51M145.12M143.32M121.55M189.07M200.48M196.19M
Change in Working Capital -7.93M7.78M-0.00M-9.32M9.31M-1.97M-5.42M-1.57M6.99M-5.42M
Change in Receivables -0.07M-0.01M0.03M37.55M33.36M29.98M-1.46M32.88M0.03M27.62M32.93M-5.54M40.52M46.16M38.70M51.12M48.20M54.82M47.49M53.33M43.61M
Change in Account Payables -8.86M9.00M-0.00M-4.54M4.54M-4.01M-1.65M4.25M-1.65M
Cash from Operations 17.16M21.32M0.01M16.41M-16.40M7.06M0.61M4.00M-4.59M0.61M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.83M1.80M5.72M3.70M
Depreciation & Amortization (CF) 2.30M2.57M0.00M4.52M-4.51M2.06M2.19M2.07M-4.26M2.19M
Investing Activities
Capital Expenditures -0.40M6.21M-0.00M-5.43M5.43M-1.96M-0.21M-0.52M0.73M-0.21M
Cash from Investing Activities -1.10M-4.18M-0.00M-7.72M7.71M-2.56M-0.37M6.39M-6.01M-0.38M87.35M
Financing Activities
Cash from Financing Activities -2.11M1.36M-0.00M-25.01M24.98M-2.38M-2.89M-0.45M3.33M-2.89M
Additional items
Exchange Rate Effect -11.60M5.61M0.01M0.11M-0.30M-0.65M0.40M-9.65M9.23M0.41M
Beginning Cash Balance 74.35M180.81M205.16M206.62M188.30M183.32M0.19M189.67M189.96M184.78M105.03M51.89M
Free Cash Flow 17.55M15.11M0.01M21.84M-21.82M9.02M0.82M4.52M-5.32M0.82M
Net Cash Flow 13.95M18.50M0.00M-16.32M16.30M2.12M-2.65M9.94M-7.27M-2.65M87.35M